12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers
Gelteq (NASDAQ:GELS) stock moved upwards by 20.3% to $0.84 during Wednesday's after-market session. The company's market cap stands at $5.6 million.
Nyxoah (NASDAQ:NYXH) shares increased by 12.58% toread more...
Benzinga
More News
INSP Raises 2026 Outlook as Reimbursement Headwinds Start to Ease
Inspire Medical raised its 2026 outlook after a Q2 beat, as Inspire V mix and cost control offset weak U.S. procedure activity.
Zacks
What's Going On With Nyxoah Stock Tuesday?
Nyxoah (NYXH) raises $95M via public offering to fund U.S. commercial growth and Genio system R&D. Stock ticks up in premarket.read more...
Benzinga
FDA Milestones Fueling Expansion
The biotechnology sector delivered several notable developments. $TNGX, $NTHI, $AIM, $AZN, $NRIX, $NYXH
24-7 Market News
Why Is NYXH Stock Falling Today?
The company priced its stock offering on Friday at a steep discount, with proceeds to be used to expand commercialization activities in the United States.
Stocktwits
Nyxoah SA (NYXH) Reports Q1 Loss, Tops Revenue Estimates
Nyxoah (NYXH) delivered earnings and revenue surprises of +19.88% and +4.59%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Evolent Health (EVH) Reports Q1 Loss, Misses Revenue Estimates
Evolent Health (EVH) delivered earnings and revenue surprises of +57.17% and -6.68%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Nyxoah (NYXH) Projected to Post Earnings on Tuesday
Nyxoah (NASDAQ:NYXH) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 12. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-12-nyxoah-sa-stock...
MarketBeat
Nyxoah SA (NYXH) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Nyxoah (NYXH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks
Tenet Healthcare (THC) Q1 Earnings Top Estimates
Tenet (THC) delivered earnings and revenue surprises of +14.39% and -0.36%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?